Akebia Therapeutics
AKBA
#7494
Rank
A$0.61 B
Marketcap
A$2.32
Share price
-3.14%
Change (1 day)
-25.97%
Change (1 year)

Akebia Therapeutics (AKBA) Fails to deliver data

Key failure to deliver metrics for Akebia Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Akebia Therapeutics (AKBA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Akebia Therapeutics (AKBA) - since 2014

Volume in USD (price x number of shares), data since 2014

Akebia Therapeutics (AKBA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$4.09 M-14.97%
2024A$4.81 M79.6%
2023A$2.68 M-41.28%
2022A$4.56 M8.92%
2021A$4.19 M-18.58%
2020A$5.15 M43.43%
2019A$3.59 M-62.25%
2018A$9.51 M238.71%
2017A$2.8 M-25.14%
2016A$3.75 M92.2%
2015A$1.95 M-88.22%
2014A$16.56 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
A$5.75 MA$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.77 MA$0.12 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
A$54.31 MA$94.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
N/AA$0.36 M๐Ÿ‡บ๐Ÿ‡ธ USA